Petx stock yahoo

22 Nov 2019 Real-time trade and investing ideas on Aratana Therapeutics Inc. PETX from the largest community of traders and investors. 17 Jul 2019 Aratana Theraptcs stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 5 Pet Stocks Fetching Big Returns | InvestorPlace Oct 30, 2013 · Plus, all five analysts following PETX stock give it a “buy” rating and the consensus price target is over $36, representing almost 75% upside from current levels. Compare Brokers. Did Hedge Funds Drop The Ball On Aratana ... - Yahoo Jun 29, 2019 · The largest stake in Aratana Therapeutics Inc (NASDAQ:PETX) was held by Broadfin Capital, which reported holding $26.1 million worth of stock at the end of March.It was followed by Engaged Capital with a $8.7 million position. Other investors bullish on the company included Impax Asset Management, Moore Global Investments, and Renaissance Technologies. Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings ...

Is Aratana Therapeutics (PETX) Stock a Solid ... - Yahoo

Aratana Therapeutics, Inc. | $PETX Stock | Shares Fall On ... Mar 14, 2017 · Aratana Therapeutics, Inc. (NASDAQ: PETX) Aratana Therapeutics, Inc. (PETX), a development-stage biopharmaceutical company yesterday reported their fourth quarter and full year 2016 financial results. Aratana reported adjusted fourth quarter earnings of a loss of $0.35 per share which beat analyst expectations of a loss of $0.43 per share. PETX, ADSW, AQ Shareholder Alert: Halper Sadeh LLP ... - Yahoo Jun 06, 2019 · PETX, ADSW, AQ Shareholder Alert: Halper Sadeh LLP Reminds Investors of Class Action Lawsuits Filed Against Aratana Therapeutics, Inc., Advanced Disposal Services PETX Historical Stock Prices PETX (PETX) has the following price history information. Looking back at PETX historical stock prices for the last five trading days, on July 12, 2019, PETX opened at $5.05, traded as high as $5.08 and as low as $4.92, and closed at $4.98. Trading volume was a total of 218.60K shares.

PETX -- Is Its Stock Price A Worthy Investment? Learn More.

Aratana Therapeutics, Inc. | $PETX Stock | Shares Spike Up ... Aug 16, 2016 · Aratana Therapeutics, Inc. (NASDAQ: PETX) Aratana Therapeutics, Inc. (PETX), a development-stage biopharmaceutical company yesterday announced that the FDA granted approval of NOCITA. NOCITA is a local anesthetic that is used in post-operative analgesia for cranial cruciate ligament surgery in dogs. The company believes that Nocita will start to be used by veterinarians in … Aratana Therapeutics, Inc. (NASDAQ:PETX): Are Analysts ... Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Aratana Therapeutics, Inc.'s (NASDAQ:PETX): Aratana Therapeutics, Inc., a … PETX: Message Board for Aratana Therapeutics, Inc ... ADMIN UPDATE: Considering the growing volume of information surrounding the Coronavirus outbreak and the need to organize & deal with it on any variety of levels, we have started adding new boards around various subject matter areas of interest, such as Coronavirus: Tracking Government Communications and Coronavirus: Laughter is the Best Medicine.

Mar 14, 2017 · Aratana Therapeutics, Inc. (NASDAQ: PETX) Aratana Therapeutics, Inc. (PETX), a development-stage biopharmaceutical company yesterday reported their fourth quarter and full year 2016 financial results. Aratana reported adjusted fourth quarter earnings of a loss of $0.35 per share which beat analyst expectations of a loss of $0.43 per share.

Analyzing Aratana Therapeutics (NASDAQ:PETX) stock? View PETX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Aratana Therapeutics Stock Price History + Charts (PETX ...

Mar 11, 2019 · Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. Biogen Inc (NASDAQ: BIIB) announced an Aratana Therapeutics (NASDAQ:PETX) - Benzinga Sep 07, 2016 · Bruce Jackson of Lake Street assumes coverage of Aratana Therapeutics Inc (NASDAQ: PETX) with a Buy rating and $15 target price, saying twelve additional new products in the

Their stock opened with $6.00 in its Jun 27, 2013 IPO. Stock Symbol NASDAQ: PETX Valuation at IPO $223M Money Raised at IPO $34.5M IPO Share Price  アラタナ・セラピューティクス【PETX】の企業情報。NYSE(ニューヨーク証券取引所)と NASDAQに上場している全銘柄の株価やチャート、業績などを網羅。ADR日本株や  PCYC (PCYC) has the following price history information. Looking back at PCYC historical stock prices for the last five trading days, on May 19, 2015, PCYC  29 Apr 2019 The stock price was $4.72/share right before closing. Interactive Brokers subtracted the $2.63 from the basis and treated it as a capital gain. So if  Historical daily stock prices for Immune Design since 2014 adjusted for splits and dividends. Open, high, low, close (OHLC) Immune Design - 4 Year Stock Price History | IMDZ Aratana Therapeutics (PETX), United States, $0.238B, 0.00.